AP-SA02
AP-SA02-101
Phase 2 mab completed
Quick answer
AP-SA02 for Bacteremia is a Phase 2 program (mab) at Armata Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Armata Pharmaceuticals
- Indication
- Bacteremia
- Phase
- Phase 2
- Modality
- mab
- Status
- completed